Alpha Teknova, Inc. (TKNO) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Alpha Teknova, Inc.'s filing signal turned positive.

Alpha Teknova, Inc. is a producer of critical reagents for the life sciences industry, serving over 3,000 customers including pharmaceutical, biotechnology, and diagnostic companies, as well as academic and government institutions. The company leverages proprietary, adaptable manufacturing processes to deliver high-quality, custom, made-to-order products with short turnaround times, supporting customers from discovery through commercialization. Its product portfolio includes pre-poured media plates, liquid microbial culture media and supplements, and molecular biology reagents. In 2025, Lab Essentials accounted for 76.6% of revenue, while Clinical Solutions contributed 18.9%. The company emphasizes deep customer relationships driven by quality, regulatory expertise, and rapid delivery, evidenced by a 95% customer retention rate for larger accounts in 2025.

Revenue is driven by the sale of catalog and custom-specified reagents, including pre-poured media plates, liquid microbial culture media, and molecular biology reagents. The company benefits from customers progressing through development stages, leading to increased demand for higher-value custom and GMP-grade products.